Skip to content

Clinical trials

Phase 3 Pulmonary Disease, Chronic Obstructive trials in Mexico

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Disease, Chronic Obstructive Phase: Phase 3 Country / region: Mexico Clear all

55 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20031
20041
20052
20062
20071
20097
20102
20115
20121
20133
20143
20153
20162
20193
20202
20213
20223
20233
20243
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed48
Recruiting4
Terminated2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca14
GlaxoSmithKline14
Sanofi7
Novartis Pharmaceuticals6
Boehringer Ingelheim5
Chiesi Farmaceutici S.p.A.3
Pearl Therapeutics, Inc.2
Bayer1
Eli Lilly and Company1
Hoffmann-La Roche1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Disease, Chronic Obstructive55
Bronchitis, Chronic3
Lung Diseases3
Asthma1
Bronchial Diseases1
Cardiovascular Diseases1
Diabetes Mellitus1
Lung Diseases, Obstructive1
Respiratory Tract Diseases1

Trials

Showing 1 to 25 of 55. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.